Reverse engineering synthetic antiviral amyloids. Nature Communications; doi.org/10.1038/s41467-020-16721-8. Michiels, E., Roose, K., Gallardo, R. et al. (2020)
Nature Communications; doi.org/10.1038/s41467-020-16721-8.
